Pharmaceuticals, Biotechnology and Life Sciences
Diplomat Pharmacy reported on Monday that it is a member of a limited panel of specialty pharmacies selected to distribute Ninlaro as a treatment for patients with relapsed and/or refractory multiple myeloma.
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil…
A medical device company Akers Biosciences has appointed John J. Gormally as Chief Executive Officer from the global medical technology company Becton Dickinson
The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS.
The Swiss-based company Geistlich Pharma AG is recalling batch of Decalcit, vitamin D and calcium chewable tablets, from the market.
Biosense Webster has acquired Coherex Medical, Inc. a privately held medical device company based in Salt Lake City, Utah.
Janssen Research & Development, LLC has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for Invokamet extended release (XR).
Bayer has submitted an application for marketing authorization in both the European Union and in the United States for LCS-16, a new low-dose levonorgestrel-releasing intrauterine system
Sanofi and AstraZeneca have announced a direct exchange of 210,000 compounds from their respective, proprietary compound libraries.
Mylan’s subsidiaries were sued Warner Chilcott and Qualicaps in connection with the filing of an ANDA with the FDA for Mesalamine Delayed-release Capsules.